Trade PSNL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Personalis, Inc. (PSNL) is trading at US$16.40, up 1.05% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.96B. Over the past 52 weeks, PSNL has traded between US$4.96 and US$18.89. On Syfe you can trade PSNL with $0 commission and add it to your watchlist.
| Previous close | US$16.23 |
|---|---|
| Market cap | US$1.96B |
| 52-week range | US$4.96 – US$18.89 |
| Volume | 3.14M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Personalis, Inc.
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.
Year: 2019
-- Earnings Flash (PSNL) Personalis, Inc. Reports Q2 Revenue $22.4M, vs. FactSet Est of $16.7M
Aug 4, 8:13 PM · MT Newswires
Personalis, Inc. (PSNL) stock is trading at US$16.40, +1.05% from the previous close of US$16.23.
The market cap for Personalis, Inc. (PSNL) stock is approximately US$1.96B.
The 52-week high for Personalis, Inc. (PSNL) stock is US$18.89.
The 52-week low for Personalis, Inc. (PSNL) stock is US$4.96.
Personalis, Inc. (PSNL) does not currently pay a dividend.
Stay on top of PSNL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
